New

Ask Wove anything about tariffs.

Try Tariff Assistant

Metoprolol Succinate Extended-Release 100mg Capsules

Extended-release capsules with 100mg metoprolol succinate for once-daily treatment of high blood pressure and heart conditions. Falls under HTS 3004.90.92.17 as a mixed product in measured doses for therapeutic cardiovascular use, retail-packed.

Import Duty Rates by Country of Origin

Origin CountryMFN RateCh.99 SurchargesTotal Effective Rate
🇨🇳ChinaFree+100.0%100%
🇲🇽MexicoFree+100.0%100%
🇨🇦CanadaFree+100.0%100%
🇩🇪GermanyFree+15.0%15%
🇯🇵JapanFree+15.0%15%

Alternative Classifications

This product could be classified differently depending on its characteristics or intended use.

3004.90.10Lower: Free vs 100%

If put up in forms for parenteral administration like injectables

Parenteral metoprolol products shift to earlier subheadings in 3004, separate from oral measured doses.

3002.13.00Same rate: 100%

If classified as immunological products like antibody conjugates

Per chapter notes, immunological peptides/proteins go to 3002, excluding typical beta-blocker formulations.

3824.99Lower: 17.5% vs 100%

If in bulk suspension without measured doses

Unpackaged chemical preparations not for retail therapeutic use fall under Chapter 38.

Not sure which classification is right?

The Tariff Assistant works through the GRI rules on your specific product to reach the right HTS code — and can price the duty on it in the same conversation.

Import Tips & Compliance

• Provide stability data for extended-release formulation during customs to avoid reclassification as standard release

• Comply with USP standards for dissolution testing in import documentation

• Label clearly as 'extended-release' to distinguish from immediate-release under the same HTS

Related Products under HTS 3004.90.92.17